Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update
Posted
Shanthi Rexaline (via Benzinga)
As the demand for obesity drugs continues to surge, biopharma companies are eagerly seizing the opportunity to capitalize on the trend.
read more
Continue reading at Benzinga ยป
Keywords
AMGN,
ARK Invest,
ARKG,
Biotech,
Cathie Wood,
Equities,
Long Ideas,
News,
obesity drug,
Specialty ETFs,
Top Stories,
Trading Ideas,
ETFs,
AMGN,
US0311621009,
ARKG,
Long Ideas,
News,
Biotech,
Equities,
Specialty ETFs,
Top Stories,
Trading Ideas,
ETFs,
Benzinga
